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ABSTRACT 
Aims: We designed this study to get insight into the disorder of lipid metabolism during cho-
lesterol gallstone formation and evaluate the effect of ursodeoxycholic acid on the improve-
ment of bile lithogenicity and on expression of lipid related genes. 
Methods: Rabbit cholesterol gallstone models were induced by high cholesterol diet. Bile, 
blood and liver tissues were obtained from rabbits after 0, 1, 2, 3, 4 and 5 weeks. Bile and 
blood lipids were measured enzymatically. 3-hydroxy-3-methylglutaryl-coenzyme A reduc-
tase (HMGCR), cytochrome P450, family 7, subfamily A, polypeptide 1 (CYP7A1) and sterol 
carrier protein 2 (SCP2) mRNA expressions were detected by using quantitative real-time 
RT-PCR. Cholesterol saturation index (CSI) was calculated by using Carey table to represent 
the bile lithogenicity. 
Results: Rates of gallstone formation of the 4 and 5 week treatment groups were 100 %, but 
that of the ursodeoxycholic acid treatment group was only 33.3 %. Expression of HMGCR 
and SCP2 mRNA in the 4 week group was upregulated and that of CYP7A1 mRNA de-
creased as compared with the 0 week group. Ursodeoxycholic acid could significantly extend 
nucleation time of bile and lower CSI. Ursodeoxycholic acid could reduce the expression of 
SCP2, but couldn’t influence expression of HMGCR and CYP7A1.  
Conclusions: Abnormal expression of HMGCR, CYP7A1 and SCP2 might lead to high litho-
genicity of bile. Ursodeoxycholic acid could improve bile lipids and lower bile lithogenicity, 
thereby reducing the incidence of gallstones. So it might be a good preventive drug for cho-
lesterol gallstones. 
 
Keywords: cholesterol gallstones, HMGCR, CYP7A1, SCP2 mRNA, bile lipids, CSI, rabbit 
models  
 
 
INTRODUCTION 
Gallstone disease is one of the most 
common gastrointestinal diseases. World-
wide prevalence rates scatter between 5 % 
and 20 %, but may be as high as 70 % in 
female American Indians. Gallstone disease 
is a multifactorial disease based on a com-
plex interaction of environmental and ge-
netic factors (Lammert and Sauerbruch, 
2005; Portincasa et al., 2006; Marschall and 
Einarsson, 2007). More than 90 % of gall-
stones consist mainly of cholesterol and are 
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formed within the gallbladder. Cholesterol 
hypersaturation of bile is a prerequisite for 
the formation of such stones. Hypersecre-
tion of cholesterol in bile leading to the 
formation of lithogenic bile is believed to 
be the major cause of cholesterol gallstones 
(Venneman and van Erpecum, 2010). Fur-
thermore, these changes are closely related 
to the disorders of lipid metabolism in liver. 
However, during the formation of choles-
terol gallstones, different links in the dis-
turbance of cholesterol metabolism and 
their effects in lithogenesis still have many 
controversies.  
Bile formation is essential for the re-
moval of excess dietary cholesterol. Cyto-
chrome P450, family 7, subfamily A, poly-
peptide 1 (CYP7A1) catalyzes the first rate-
limiting reaction of cholesterol catabolic 
pathway converting cholesterol to bile salts 
which are essential for keeping cholesterol 
molecules solubilized in bile. Some investi-
gators observed tendencies for reduced 
CYP7A1 activity in gallstone disease pa-
tients (Reihnér et al., 1991; Ito et al., 1996). 
Xie et al. (2009) found that the AU-rich 
RNA binding-protein Apobec-1 mediated 
post-transcriptional regulation of murine 
CYP7A1 expression and increased suscep-
tibility to diet-induced gallstone formation. 
Other research indicated that there was no 
difference of cholesterol 7-hydroxylase 
mRNA expression in gallstone susceptible 
mice, but in the gallstone resistant mice the 
expression level of 7-hydroxylase mRNA 
increased (Tazuma et al., 1998). Khanuja et 
al. (1995) found the regulation of the rate-
limiting enzyme in cholesterol biosynthesis, 
3-hydroxy-3-methylglutaryl-coenzyme A 
reductase (HMGCR), may be pivotal in de-
termining the occurrence and severity of 
cholesterol hypersecretion and hence litho-
genicity of gallbladder bile. Lammert et al. 
(1999) found that HMGCR in cholesterol 
synthesis was not down-regulated in C57L 
mice fed a lithogenic diet which contains 
large amounts of cholesterol. Caroli-Bosc et 
al. (2001) found that increased activity of 
HMGCoA reductase corrsponds with a rise 
in hepatic cholesterol synthesis, so that the 
Cholesterol Saturation Index of bile would 
also go up. Some researchers found the 
overexpression of sterol carrier protein 2 
(SCP2) might accelerate the transportation 
of cellular cholesterol, increase the choles-
terol in the bile and promote the formation 
of gallstones (Ito et al., 1996; Fuchs et al., 
1998). Our former finding indicated that 
SCP2 might be one of the genetic factors 
contributing to cholesterol gallstone for-
mation (Cui et al., 2011). 
This study is aimed to investigate the li-
pid changes in blood and bile in order to 
find out the relationship between the disor-
der of lipid metabolism and the formation 
of cholesterol gallstones. We also evaluated 
the effect of ursodeoxycholic acid on the 
improvement of lithogenicity of rabbit 
model bile and expression of lipid related 
genes.  
 
MATERIALS AND METHODS 
Animals, diets and treatment 
This study was approved by the Animal 
Care and Use Committee in Tianjin Nankai 
Hospital. Male and female white Japanese 
rabbits were obtained from the Experi-
mental Animal Center of Tianjin Medical 
University. They were divided randomly 
into 0 week group (0W) as a control group 
and as 1 to 5 week groups (1W, 2W, 3W, 
4W, 5W) as five experimental groups, and 
ursodeoxycholic acid treatment group (U) 
each constisting of seven rabbits. Rabbits in 
control group were given a normal diet, but 
those in experimental groups were fed with 
1.2 % cholesterol diet for one to five weeks 
(1W to 5W). Rabbits in the ursodeoxy-
cholic acid treatment group (U) were fed 
with 1.2 % cholesterol diet for four weeks 
and were simultaneously orally treated with 
ursodeoxycholic acid (75 mg/kg) by gavage 
(Liu and Jun, 1997). All animals were 
maintained in separate cages with free ac-
cess to water. 
 
Blood, bile and liver sampling 
At the end of each experiment, follow-
ing an overnight fasting, animals were anes-
thetized. After the collection of samples, 
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rabbits were euthanatized. Blood samples 
were collected for the measurement of 
blood lipids and portions of liver were ob-
tained for the histological analysis and the 
analysis of gene expression. Bile specimen 
was aspirated from gallbladder and kept for 
subsequent analysis. The gallbladder was 
cut open under the microscope and the gall-
stones and cholesterol crystals were evalu-
ated.  
 
Identification of gallstones and cholesterol 
crystals 
Criteria for gallstones:  
If gallstone particles were found by in-
spection with the naked eye or large dense 
clumps of cholesterol crystals were seen 
under the microscope, samples were con-
sidered positive for gallstone formation.  
 
Quantitative criteria for cholesterol cry-
stals:  
A portion of fresh gallbladder bile was 
centrifuged, the sediment smears were ob-
served microscopically, and cholesterol 
crystals were quantified according to Juni-
per standard (Block and Priest, 1967). 
 
Nucleation time of gallbladder bile 
Biles were centrifuged 100,000 x g at 
37 °C for 2 hours in order to remove the 
cholesterol crystals. Biles were taken and 
put in the incubator at 37 °C and were ob-
served every day under the polarizing mi-
croscope. The time when cholesterol mono-
hydrate crystals appeared was named nu-
cleation time and the observation time was 
no more than 21 days (Holan et al., 1979).  
 
Analysis of blood lipids 
Plasma triglycerides (TG), total choles-
terol (TC), high density lipoprotein choles-
terol (HDL-C) and low density lipoprotein 
cholesterol (LDL-C) were measured on Hi-
tachi 704 Analyzer (Roche Diagnostics, In-
dianapolis) with enzymatic methods using 
the manufacturer’s reagents and instruc-
tions. 
 
Analysis of bile lipids 
The concentrations of biliary cholesterol, 
phospholipids, and total bile acids were 
measured using enzymatic techniques 
(Roda et al., 1975; Qureshi et al., 1980; 
Talalay, 1960). Cholesterol Saturation In-
dex (CSI) was calculated by using the Car-
ey table (Carey, 1978).  
 
Quantitative real-time RT-PCR  
Total RNA was prepared from liver tis-
sue by using the Trizol method. Briefly, 
1 µg RNA was reverse-transcribed by using 
random primer hexamers. Amplification 
was carried out with an ABI 7300 real-time 
PCR system (Applied Biosystems) using 
SYBR green I. The reference gene was 
glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH). Primer sequences for rabbit 
HMGCR (forward 5’-ATGGAATTCCAT-
GGCTGGGAGCATAGGAG-3’ and re-
verse 5’-TCCTTGAACACCTAGCATCT-
GC-3’), CYP7A1 (forward 5’-ATGGAAT-
TCCATCTCAAGCAAACACCATTCC-3’ 
and reverse 5’-TGCATTAACTGTGGAT-
AAAGAGC-3’), and SCP2 (forward 5’-
GCCAACGAACTCCTCACTTAT-3’ and 
reverse 5’-TTGCCATTCTTCACATCT-
ACCA-3’) were designed to span an intron-
ic sequence and were validated by PCR and 
gel analysis. 
 
Microscopy/Histology 
Liver and gallbladder tissues were fixed 
with formalin and embedded with paraffin. 
The sections were stained with hematoxylin 
and eosin (HE), and observed under a light 
microscope. Three HE sections from each 
group were scored (Zeymer et al., 1992). 
Slides were examined at high magnifica-
tion. Liver cells with steatosis and total 
cells were counted.   
 
Statistical analysis 
All data were expressed as mean ± 
standard deviation. Differences between 
control and experimental groups were eval-
uated by Chi-square test and one-way anal-
ysis of variance (ANOVA). P<0.05 was 
considered statistically significant (α=0.05). 
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RESULTS 
Analysis of rabbit gallstones 
Gallstones in gallbladder were not 
found in any animal of the 0W group fed 
with routine diet (Figure 1B). However, 
cholesterol gallstones were found in the ex-
perimental groups fed with dietary choles-
terol. All gallstones appeared as small 
brown black stones with the naked eye and 
in some cases microliths could be observed 
under the 20 x light microscope (Figure 
1C). The rate of gallstones gradually in-
creased with diet time and those of 4W and 
5W groups were 100 %, but the rate of ur-
sodeoxycholic acid treatment group was 
33.3 % (Figure 1A). The rates of gallstone 
formation between groups can be consid-
ered as statistical significance, χ2 = 27.453, 
υ = 5, P <0.01 (bilateral) (Table 1).  
Under the 100X light microscope (Fig-
ure 1D), the examination of rabbit gallblad-
der bile showed that the cholesterol mono-
hydrate crystals increased gradually with 
cholesterol diet time. The system of Juniper 
and Burson for counting microlithiasis was 
employed to evaluate the formation of gall-
stones (Table 2). The differences between 6 
groups was significant, χ2 = 33.728, υ = 5, 
P <0.01 (bilateral).  
 
Histological analysis of liver and rabbit 
gallbladder after the treatment of urso-
deoxycholic acid 
The percent of liver cells with steatosis 
was calculated by positive cells/total cells 
x100 and results are given in mean ± stand-
ard error. The section of liver in 4W group 
showed a lot of fat were accumulated in the 
liver parenchyma, there were more liver 
cells with steatosis in the 4W group 
(88.1 % ± 2.3 %) (Figure 1I) than in the 0W 
group (2.2 % ± 0.3 %) (Figure 1H) (P< 
0.05). Compared with the 4W group, the 
steatosis was alleviated in the U group 
(7.2 % ± 1.4 %) (Figure 1J) (P<0.05). The 
section of gallbladder in the 4W group 
(Figure 1F) showed some proliferation of 
epithelium and some infiltration of inflam-
matory cell, but those in the 0W group 
(Figure 1E) and U group (Figure 1G) 
showed only few of them. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Gallstone for-
mation and histological 
examination of gallblad-
der and liver. A. Quantifi-
cation of gallstone for-
mation in rabbit models by 
means of high cholesterol 
diet. B-D. Detection of 
stone particles in bile fluid: 
(B) normal bile of 0W 
group, (C) stone particles 
of 4W group, and (D) cho-
lesterol crystals of 4W 
group. E-G. Histological 
analysis of gallbladder thin 
sections stained with HE: 
(E) 0W group, (F) 4W 
group showing some prolif-
erations of epithelium and 
some infiltrations of in-
flammatory cell, and (G) U 
group. H-J. Histological 
examination of liver thin 
sections stained with HE: 
(H) 0W group, (I) 4W 
group, and (J) U group 
showing less liver cells with 
steatosis than 4W group. 0-
5 W, 0-5 week; U, urso-
deoxycholic acid treatment. 
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Table 1: Analysis of gallstone formation in rabbits 
Group Number of rabbit Number of gallstone 
rabbit 
Rate of gallstone formation ( %)* 
0W Group 7 0 0 
1W Group 7 0 0 
2W Group 7 1 14.3 
3W Group 6 2 28.6 
4W Group 7 7 100 
5W Group 6 6 100 
U Group 6 2 33.3** 
*The differences between 7 groups was significant, χ2=27.453, υ =6, P <0.01 (bilateral). 0-5 W, 0-5 
week; U, ursodeoxycholic acid treatment 
** Compared with 4W group, P<0.05 
 
Table 2: Analysis of cholesterol crystal formation in rabbits 
Group 0W 
Group 
1W 
Group 
2W 
Group 
3W 
Group 
4W 
Group 
5W 
Group 
U 
Group 
- 6 1 0 0 0 0 0 
+ 1 6 6 0 0 0 6 
++ 0 0 1 2 1 1 2 
+++ 0 0 0 3 2 1 0 
++++ 0 0 0 1 4 4 0 
The differences between 7 groups was significant, χ2=33.728, υ =6, P<0.01 (bilateral). 0-5 W, 0-5 
week; U, ursodeoxycholic acid treatment 
 
 
Changes of plasma TG, TC, HDL-c and 
LDL-c 
As shown in Figure 2D, the concentra-
tions of plasma TC and LDL-c gradually 
increased with the prolonged feeding time 
of dietary cholesterol (P<0.05). The plasma 
levels of TC (16.07 ± 1.04 mmol/L) and 
LDL-c (5.18 ± 0.51 mmol/L) in the 4W 
group were higher than those (4.17 ± 0.85, 
2.46 ± 0.89 mmol/L) in the 0W group 
(P<0.05). HDL-c showed a decreasing ten-
dency without statistical significance 
(P>0.05) whereas TG showed an increasing 
tendency also without statistical signifi-
cance (P>0.05). There were no differences 
about plasma TC, TG, HDL-c and LDL-c 
between the 4W and the U group (P>0.05). 
 
Analysis of bile cholesterol, bile acids and 
pospholipids 
As shown in Figure 2A, the bile choles-
terol of the 4W and 5W groups significantly 
increased by about 2 times as compared 
with the control group. The bile cholesterol 
of the 4W group (2.17 ± 0.37 mmol/L) was 
higher than that of the 0W group (1.20 ± 
0.65 mmol/L) (P<0.05). Total bile acids 
showed a slight increase during the dietary 
cholesterol feeding in the 2W and 3W 
groups, but then decreased in 4W and 5W 
groups, and total bile acids of 4W and 5W 
groups significantly decreased as compared 
with the control group (P<0.05). Total bile 
acid of the 4W group (6.36 ± 0.17 mmol/L) 
was lower than that of the 0W group (7.29 
± 0.26 mmol/L) (P<0.05). Bile phospholi-
pids showed a slight increase during the 
dietary cholesterol feeding in 2W and 3W 
groups, and then decreased in the 4W and 
5W groups, but there was no significant dif-
ference for bile phospholipids between 4W 
group and the control group (P>0.05). Ur-
sodeoxycholic acid could reduce the bile 
cholesterol from 2.17 ± 0.37 mmol/L (4W 
group) to 1.66 ± 0.067 mmol/L (U group) 
(P<0.05) and significantly increased the 
bile acids from 6.36 ± 0.17 mmol/L (4W 
group) to 11.23 ± 0.25 mmol/L (U group) 
(P<0.05). However, it couldn’t influence 
the bile phospholipid level.  
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Analysis of bile nucleation time and CSI 
Bile nucleation times of all animals were 
gradually  reduced from 0 to 5 weeks  (Fig-
ure 2B). The bile nucleation  time of the 4W 
group (8 ± 4 days) was significantly shorter 
than that of the 0W group (21 ± 6 days) 
(P<0.05). Compared with 4W group (8 ± 4 
days), the bile nucleation time of U group 
(15 ± 5 days) was extended (P<0.05). CSIs 
increased with the prolonged feeding time 
of dietary cholesterol (Figure 2C). CSI of 
the 4W group (1.58 ± 0.09) was significant-
ly higher than that of the 0W group (0.34 ± 
0.08) (P<0.05). CSI in the U group (0.45 ± 
0.026) significantly decreased compared 
with the 4W group (1.58 ± 0.085) (P<0.05).  
  
 
Figure 2: Analysis of bile lipids, nucleation time, CSI and blood lipids in rabbit gallstone models. A. Analy-
sis of bile lipids, showing that the U group had a higher BA level than the 4W group (*) and a lower BC level than 
the 4W group (*). B. Analysis of bile nucleation time. C. Analysis of bile CSI, showing that the U group had a low-
er CSI than the 4W group (*). D. Analysis of blood lipids, showing that there were no differences in plasma TC, 
TG, HDL-c and LDL-c between 4W and U group (n.s.). “*” indicates P<0.05. “n.s.” indicates “not significant”. BC, 
bile cholesterol; BA, bile acids; PL, phospholipid; TG, triglyceride; TC, total cholesterol; HDL-c, high density lipo-
protein cholesterol; LDL-c, low density lipoprotein cholesterol; 0-5 W, 0-5 week; U, ursodeoxycholic acid treatment 
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The mRNA expression of HMGCR, 
CYP7A1 and SCP2 in liver tissue  
As shown in Figure 3, HMGCR mRNA 
levels were increased with the prolonged 
feeding time of dietary cholesterol 
(P<0.05), but there was a valley in the 2W 
and 3W groups. The HMGCR mRNA level 
of the 4W group (4.0587 ± 0.1011) was 
higher than that of the 0W group (1.12 ± 
0.068) (P<0.05). CYP7A1 mRNA levels 
gradually decreased with the prolonged 
feeding time of dietary cholesterol 
(P<0.05). The CYP7A1 mRNA level of the 
4W group (0.3485 ± 0.0597) was lower 
than that of the 0W group (1.04 ± 0.039) 
(P<0.05). SCP2 mRNA levels were also 
gradually increased with the prolonged 
feeding time of dietary cholesterol 
(P<0.05). The SCP2 mRNA level of 4W 
group (4.96 ± 0.15) was about 5-fold higher 
than that of 0W group (1.02 ± 0.17) 
(P<0.05). Our results showed that ursode-
oxycholic acid could also reduce the ex-
pression of SCP2 from 4.96 ± 0.15 (4W 
group) to 1.76 ± 0.08 (U group) (P<0.05), 
but couldn’t significantly reduce the ex-
pression of HMGCR (P>0.05) or increase 
the expression of CYP7A1 (P>0.05) com-
pared with the 4W group.  
 
The expression differences of HMGCR, 
CYP7A1 and SCP2 mRNA between gall-
stone and non-gallstone groups 
As shown in Figure 3D and 3E, we di-
vided all the rabbits fed with high choles-
terol diet into two groups, gallstone group 
(16 rabbits) and non-gallstone group (24 
rabbits). Then we detected the mRNA ex-
pressions of HMGCR, CYP7A1 and SCP2 
in gallstone and non-gallstone groups by 
using quantitative real-time RT-PCR. 
HMGCR (2.26 ± 0.075) and SCP2 (2.18 ± 
0.179) mRNA expression in the gallstone 
group was significantly higher than those 
(1.00 ± 0.088 and 1.08 ± 0.152) in the non-
gallstone group (P<0.05). CYP7A1 mRNA 
was expressed lower in the gallstone group 
(0.699 ± 0.446) than that in the non-
gallstone group (1.04 ± 0.24) (P<0.05). Fur-
thermore CSI in the gallstone group (1.41 ± 
0.08) was significantly higher than that in 
thenon-gallstone group (0.506 ± 0.073) 
(P<0.05). 
 
DISCUSSION 
In this study, we used high cholesterol 
diet to induce rabbit cholesterol gallstones. 
The rate of gallstone formation gradually 
increased with feeding time, and the for-
mation of cholesterol monohydrate crystal 
also increased gradually. Our experiments 
indicated that 4 weeks were long enough to 
set up the rabbit cholesterol gallstone mod-
el, which was consistent with other previ-
ous studies (Zhao et al., 1998). So we chose 
4 week as an optimal time for setting up the 
gallstone model and observing the preven-
tive effect of ursodeoxycholic acid on cho-
lesterol gallstones. 
Data of previous epidemiological stud-
ies showed that levels of plasma lipoprotein 
cholesterol varied in cholesterol gallstone 
patients (Hayes et al., 1992; Busch and Ma-
tern, 1991). In normal people, the plasma 
LDL-c concentration appeared to be related 
to biliary cholesterol (Lee et al., 1985). An-
imal studies showed that in cholesterol fed 
hamsters with a VLDL-c/HDL-c ratio 
greater than 1.0, cholesterol gallstone for-
mation occurred easily (Dietschy et al., 
1993). We found that plasma TC and LDL-
c in the 4W group were 4 and 2 fold those 
in the 0W control group respectively. LDL-
c is a cholesterol-rich lipoprotein (North et 
al., 2006), and LDL-c cholesterol is the 
main resource of cholesterol from plasma to 
the liver. In this model, high cholesterol 
diet could lead to a large accumulation of 
cholesterol in the blood. Under this circum-
stance, cholesterol couldn’t be cleared 
through the bile acid pathway, but it might 
be secreted into the bile directly.  
Our results showed that the cholesterol 
level of gallbladder bile increased with cho-
lesterol diet time. Under the high cholester-
ol diet, there was often an impaired bile ac-
id synthesis, so the excessive cholesterol is 
mainly excreted into the bile and then leads 
to high lithogenicity of bile and gallstone 
formation. Bile acids increased in the first
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Figure 3: The expression of lipid related genes in rabbit gallstone models. A-C. Expression of SCP2 (A), 
CYP7A1 (B) and HMGCR mRNA (C) during cholesterol gallstone formation: (A) The SCP2 mRNA level is lower 
in the U group than in the 4W group (*); (B and C) mRNA levels of CYP7A1 and HMGCR, do not differ between 
the U and 4W group (n.s.). D. Expression of SCP2, CYP7A1 and HMGCR between gallstone and non- gallstone 
groups. E. CSI of the gallstone and non-gallstone groups, showing a higher CSI in the gallstone group (*). “*” indi-
cates P<0.05. “n.s.” indicates “not significant”. 0-5 W, 0-5 week; U, ursodeoxycholic acid treatment 
 
 
stage and then decreased with feeding time. 
The transient increase of bile acids may be 
due to the accumulation of cholesterol 
which induced higher expression of 
CYP7A1 and enhanced the bile acid syn-
thesis, but after that we found that the se-
cretion of bile acids decreased. The possible 
reasons were that the long-term excessive 
exogenous cholesterol might inhibit the ac-
tivity and expression of CYP7A1 and fur-
ther reduce the bile acid synthesis (Rudel et 
al., 1994). In our study, we found that bile 
CSI gradually increased and bile nucleation 
time was gradually shortened in the process 
of cholesterol stone formation.  
When we compared the gallstone and 
non-gallstone groups, we found that the ex-
pression of HMGCR was elevated in the 
former, and at the same time CSI was sig-
nificantly higher in the gallstone group than 
that in the non-gallstone group. It was 
found that the expression of HMGCR 
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mRNA increased with cholesterol diet time. 
This indicated that high cholesterol diet 
might induce the overexpression of 
HMGCR, increase bile CSI and promote 
the formation of gallstones. We found that 
the expression of CYP7A1 increased in the 
2W and 3W group, and then decreased in 
the 4W and 5W group. This indicated that 
the high cholesterol diet may impair ex-
pression of CYP7A1 and the expression of 
CYP7A1 decreased in the gallstone group 
compared with the non-gallstone group. 
The reason may be that the conversion of 
cholesterol to bile acids was blocked, which 
might cause accumulated cholesterol in 
hepatocytes to be excreted directly into bile. 
We also found that the expression of SCP2 
increased gradually with feeding time, and 
the expression of SCP2 was elevated in the 
gallstone group compared with the non-
gallstone group. This indicates that the high 
cholesterol diet might induce the overex-
pression of SCP2. Therefore, during the 
gallstone formation induced by high choles-
terol diet, there were abnormal expressions 
of HMGCR, CYP7A1 and SCP2.  
In this study, we chose ursodeoxycholic 
acid as a preventive drug for gallstone for-
mation and used the 4W group as the con-
trol group for comparison. The rate of gall-
stone formation in the 4W group was 
100 %, but the rate in the U group was 
33.3 %. Compared with the 4W group, the 
steatosis was significantly alleviated in the 
U group. This indicates that ursodeoxy-
cholic acid might improve the steatosis of 
liver. The serum cholesterol and LDL-c in 
the U group was not lower than that in the 
4W group. Obviously, ursodeoxycholic ac-
id can’t improve blood lipid components 
under the overload of cholesterol in the 
body. We also found that ursodeoxycholic 
acid could reduce the gallbladder bile cho-
lesterol and significantly increase the bile 
acids in bile, but it couldn’t influence the 
bile phospholipid level. Ursodeoxycholic 
acid could significantly lower CSI of bile, 
extend the nucleation time of bile and re-
duce the expression of SCP2, but couldn’t 
influence the expression of HMGCR and 
CYP7A1 during the formation of gall-
stones.  
In a word, our result was consistent with 
reports about ursodeoxycholic acid from 
other researchers. The early and long-term 
application of ursodeoxycholic acid could 
prolong cholesterol nucleation time, im-
prove gallbladder emptying (Sharma et al., 
1998; van de Heijning et al., 1999), and re-
duce pain and inflammation (Tomida et al., 
1999). We found that ursodeoxycholic acid 
could increase bile acids and reduce biliary 
cholesterol, so it can increase the solubility 
of cholesterol, thereby reducing the inci-
dence of gallstones. Finally ursodeoxy-
cholic acid can also alleviate the steatosis of 
liver under high cholesterol diet. So it 
might be a good preventive drug for choles-
terol gallstones.  
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